Netherlands· NL-e3c10d416345

Imeros 3% w/v oplossing voor injectie

A mepivacaine product containing mepivacainehydrochloride, registered in Netherlands by Intermed S.A.. The same ATC class is registered in 18 of our 19 countries.

ATC N01BB03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mepivacainehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mepivacaine is registered in 18 of 19 countries.

Countries holding a registration under ATC N01BB03 (mepivacaine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
10 of them publish a price we can compare per daily dose

Search mepivacaine products by name

Mepivacaine · ATC N01BB03

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MEPIVACAINEHYDROCHLORIDE
Manufacturer: Intermed S.A.
Country: Netherlands (NL)
ATC code: N01BB03
ATC class: Mepivacaine
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
126291

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

24 interactions on record for mepivacaine.

Graded by severity as the source publishes them — 23 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check mepivacaine against other medicines How interaction checks work

Mepivacaine · interactions on record

24 records

23 moderate
1 minor

Most severe, free to view

LidocainA01AE01moderate
TetracainA01AE02moderate
LidocaineC05AD01moderate
TetracaineC05AD02moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mepivacaine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mepivacaine products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Mepinaest Purum, Scandonest Ohne Vasokonstriktor
Belgium · Mepicart, Mepivastesin
Bulgaria · Мепидентал, Скандонест
Cyprus · Imeros, Mepidental
Czechia · Scandonest
Germany · Meaverin, Mecain
Denmark · Carbocain, Mepidental
Estonia · Scandivin, Scandonest
Spain · Isogaine, Mepivacaína B. Braun
Finland · Mepidental, Scandonest
France · Carbocaine, Mepivacaine B. Braun
United Kingdom (Northern Ireland) · Biocaine Plain, Mepivacaine Hydrochloride Accord Healthcare
Greece · Imeros, Scandonest
Croatia · Scandonest
Hungary · Scandonest
Ireland · Scandonest
Iceland · Carbocain, Carbocain Dental
Italy · Carbosen, Mepicain
Lithuania · Mepivastesin, Scandivin
Luxembourg · Mepicart, Scandicaïne
Latvia · Scandivin, Scandonest
Norway · Carbocain Dental, Scandonest Plain
Poland · Mepidont, Mepivastesin
Portugal · Isogaine, Mepivacaína Braun
Romania · Mepidental, Mepivacaina Normogen
Sweden · Carbocain, Carbocain Dental
Slovenia · Scandicaine
Slovakia · Mepivastesin, Scandonest

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f27274de-da0d-47d6-ad10-329dd1e7b377
GET /v1/drugs/f27274de-da0d-47d6-ad10-329dd1e7b377?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie",
  "route": "Perineuraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h126291_smpc.pdf",
  "strength": null,
  "atc_label": "Mepivacaine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg126291",
  "excipients": [
    "NATRIUMCHLORIDE",
    "NATRIUMHYDROXIDE (E 524)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "MEPIVACAINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h126291.pdf",
  "authorised_at": "2021/09/24",
  "procedure_number": "NL/H/5083/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "126291",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about mepivacaine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console